July 17, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
A proprietary extended-release oral minoxidil tablet induced rapid, robust and consistent hair growth in women with female pattern hair loss, according to topline results. Results from study 207 showed VDPHL01 (Veradermics) increased hair count for women who received once or twice daily dosing for 6 months and was generally well tolerated with no evidence of serious adverse events, including
July 17, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss

Veradermics declares first efficacy win in women for hair loss drug

Veradermics' Oral Hair Loss Drug For Women Shows Results In Just 2 Months - Veradermics (NYSE:MANE)

Why Hollywood’s Follicle-Challenged Stars Are Harvesting Their Hair

Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss

New Peer-Reviewed Study Published in Dermatology and Therapy Adds to Clinical Evidence Showing Nutrafol Hair Growth Nutraceuticals Improve Hair Growth in Women

The Strongest Topical Treatments for Advanced Hair Loss

Q32 bounces back to claim study success for alopecia drug